Cost-effectiveness of utidelone and capecitabine versus monotherapy in anthracycline- and taxane-refractory metastatic breast cancer by Mulan Chen, Heng Zhang, Xiaoyan He, Yingtao Lin

Get full text

Atezolizumab plus bevacizumab and chemotherapy as first-line therapy for cervical cancer: a cost-effectiveness analysis in the US by Yingtao Lin, Cijuan Li, Chang Wang, Jian Chen, Yuanqing Huang

Get full text

Cost-effectiveness analysis of toripalimab plus chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer in China by Mengdie Zhang, Kai Xu, Yingtao Lin, Chongchong Zhou, Chongchong Zhou, Yuwen Bao, Lingli Zhang, Xin Li, Xin Li, Xin Li

Get full text

Prognostic value of apparent diffusion coefficient in neuroendocrine carcinomas of the uterine cervix by Jian Chen, Ning Ma, Mingyao Sun, Li Chen, Qimin Yao, XingFa Chen, Cuibo Lin, Yongwei Lu, Yingtao Lin, Liang Lin, Xuexiong Fan, Yiyu Chen, Jingjing Wu, Haixin He

Get full text